Skip to main content
SpringerLink
Log in

Defining ‘acute on chronic liver failure’: an identity crisis!

  • Forum
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758–69.

    Article  CAS  PubMed  Google Scholar 

  2. Mathurin P. The use of corticosteroids in severe alcohol hepatitis: we need to look beyond this controversy. J Hepatol. 2010;53:392–3.

    Article  PubMed  Google Scholar 

  3. Orrego H, Blake JE, Blendis LM, Medline A. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology. 1987;92:208–14.

    CAS  PubMed  Google Scholar 

  4. Ramond MJ, Poynard T, Rueff B, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med. 1992;326:507–12.

    Article  CAS  PubMed  Google Scholar 

  5. Mathurin P, Mendenhall CL, Carithers Jr RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol. 2002;36:480–7.

    Article  CAS  PubMed  Google Scholar 

  6. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:1637–48.

    Article  CAS  PubMed  Google Scholar 

  7. Maddrey WC, Boitnott JK, Bedine MS, Weber Jr FL, Mezey E, White Jr RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193–9.

    CAS  PubMed  Google Scholar 

  8. Forrest EH, Evans CD, Stewart S, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005;54:1174–9.

    Article  CAS  PubMed  Google Scholar 

  9. Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348–54.

    Article  CAS  PubMed  Google Scholar 

  10. Dunn W, Jamil LH, Brown LS, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005;41:353–8.

    Article  PubMed  Google Scholar 

  11. Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C. Systematic review: glucocorticosteroids for alcoholic hepatitis—a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther. 2008;27:1167–78.

    Article  CAS  PubMed  Google Scholar 

  12. Wasmuth HE, Kunz D, Yagmur E, et al. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol. 2005;42:195–201.

    Article  CAS  PubMed  Google Scholar 

  13. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55 Suppl 6:vi1–12.

    Article  PubMed  Google Scholar 

  14. Sen S, Williams R, Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver. 2002;22 Suppl 2:5–13.

    PubMed  Google Scholar 

  15. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403–9.

    Article  CAS  PubMed  Google Scholar 

  16. Ortega R, Ginès P, Uriz J, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002;36:941–8.

    CAS  PubMed  Google Scholar 

  17. Jalan R, Schnurr K, Mookerjee RP, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology. 2009;50:555–64.

    Article  CAS  PubMed  Google Scholar 

  18. Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int. 2009;3:269–82.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nottingham Digestive Diseases Centre: National Institute of Health Research, Biomedical Research Unit, Queen’s Medical Centre, Nottingham University Hospitals, Nottingham, NG7 2UH, UK

    Guruprasad P. Aithal

Authors
  1. Guruprasad P. Aithal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guruprasad P. Aithal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aithal, G.P. Defining ‘acute on chronic liver failure’: an identity crisis!. Indian J Gastroenterol 29, 177–180 (2010). https://doi.org/10.1007/s12664-010-0057-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-010-0057-5

Keywords

Search

Navigation